Allied Healthcare Products Inc.
Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry in a range of hospitals and alternate site settings worldwide. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers, as well as respiratory disposable products, such as oxygen tubing … Read more
Allied Healthcare Products Inc. (AHPIQ) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, Allied Healthcare Products Inc. (AHPIQ) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | -23.92% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 28.81 |
Allied Healthcare Products Inc. - Net Assets Trend (2019–2022)
This chart illustrates how Allied Healthcare Products Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Allied Healthcare Products Inc. (2019–2022)
The table below shows the annual net assets of Allied Healthcare Products Inc. from 2019 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-06-30 | $5.23 Million | -50.53% |
| 2021-06-30 | $10.58 Million | +19.16% |
| 2020-06-30 | $8.88 Million | -25.33% |
| 2019-06-30 | $11.89 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Allied Healthcare Products Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 668834000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $52.14K | 1.00% |
| Other Components | $27.54 Million | 526.22% |
| Total Equity | $5.23 Million | 100.00% |
Allied Healthcare Products Inc. Competitors by Market Cap
The table below lists competitors of Allied Healthcare Products Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MacroAsia Corp
PSE:MAC
|
$726.46 |
|
GOLIK HLDGS
BE:GOH
|
$727.03 |
|
Vexilla Viet Nam Group JSC
VN:SVN
|
$727.25 |
|
Ice Code Games S.A.
WAR:ICG
|
$727.79 |
|
Burshane LPG (Pakistan) Ltd
KAR:BPL
|
$725.27 |
|
FANCAMP EXPLORATION
BE:3F9
|
$724.02 |
|
Amana Takaful PLC
CM:ATLN0000
|
$722.87 |
|
OptiBiotix Health Plc
LSE:OPTI
|
$722.70 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Allied Healthcare Products Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 10,579,861 to 5,234,080, a change of -5,345,781 (-50.5%).
- Net loss of 5,361,428 reduced equity.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.36 Million | -102.43% |
| Other Changes | $15.65K | +0.3% |
| Total Change | $- | -50.53% |
Book Value vs Market Value Analysis
This analysis compares Allied Healthcare Products Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-06-30 | $2.96 | $0.00 | x |
| 2020-06-30 | $2.21 | $0.00 | x |
| 2021-06-30 | $2.64 | $0.00 | x |
| 2022-06-30 | $1.30 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Allied Healthcare Products Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -102.43%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -19.82%
- • Asset Turnover: 1.37x
- • Equity Multiplier: 3.76x
- Recent ROE (-102.43%) is below the historical average (-34.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -17.74% | -6.72% | 2.03x | 1.30x | $-3.30 Million |
| 2020 | -33.95% | -9.45% | 1.62x | 2.22x | $-3.90 Million |
| 2021 | 15.95% | 4.65% | 2.05x | 1.67x | $629.20K |
| 2022 | -102.43% | -19.82% | 1.37x | 3.76x | $-5.88 Million |
Industry Comparison
This section compares Allied Healthcare Products Inc.'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $770,957,432
- Average return on equity (ROE) among peers: -24.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Allied Healthcare Products Inc. (AHPIQ) | $- | -17.74% | N/A | $726.24 |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |